LCA-0321 is a LYTAC degrader designed to specifically bind and rapidly deplete anti-TSHR autoantibodies, the underlying cause of Graves’ disease and its extrathyroidal manifestations, including ...

Fintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...

Thyroid hormones work along with many other hormones, proteins, nuclear receptors, and chemicals to help maintain a person's BMR. A person's body burns calories (energy) during physical activity and ...

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Viking Therapeutics in a research note issued on Thursday, February 6th. HC Wainwright analyst J. Pantginis expects that ...

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They currently have a ...

One boy did not increase his growth rate, even though the serum thyroid hormone concentrations (TSH 46.0 mU/l ... two had thyrotoxicosis associated with high concentrations of TSH receptor stimulating ...